Epoch Investment Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$84.3M Sell
701,092
-9,359
-1% -$1.08M 0.51% 79
2025
Q4
$74.8M Buy
710,451
+17,339
+3% +$1.63M 0.42% 92
2025
Q3
$58.2M Sell
693,112
-27,546
-4% -$2.27M 0.32% 113
2025
Q2
$57M Buy
720,658
+12,810
+2% +$1.02M 0.3% 124
2025
Q1
$63.5M Buy
707,848
+25,772
+4% +$2.41M 0.33% 120
2024
Q4
$67.9M Sell
682,076
-159,034
-19% -$16.4M 0.33% 114
2024
Q3
$95.5M Sell
841,110
-502,987
-37% -$59.8M 0.43% 80
2024
Q2
$166M Buy
1,344,097
+127,214
+10% +$16.4M 0.76% 37
2024
Q1
$161M Buy
1,216,883
+602
+0% +$74.2K 0.71% 43
2023
Q4
$133M Sell
1,216,281
-147,117
-11% -$15.3M 0.6% 44
2023
Q3
$140M Sell
1,363,398
-17,274
-1% -$1.86M 0.9% 23
2023
Q2
$159M Sell
1,380,672
-18,961
-1% -$2.15M 0.92% 20
2023
Q1
$149M Buy
1,399,633
+20,048
+1% +$2.16M 0.89% 21
2022
Q4
$153M Sell
1,379,585
-536,467
-28% -$54.8M 0.91% 23
2022
Q3
$165M Sell
1,916,052
-135,185
-7% -$12.1M 1.08% 13
2022
Q2
$187M Sell
2,051,237
-969,709
-32% -$86M 1.1% 11
2022
Q1
$248M Buy
3,020,946
+316,207
+12% +$24.9M 1.21% 11
2021
Q4
$207M Buy
2,704,739
+205,551
+8% +$16.4M 1.05% 18
2021
Q3
$188M Buy
2,499,188
+134,414
+6% +$10.2M 1.04% 20
2021
Q2
$184M Sell
2,364,774
-1,080,456
-31% -$80.4M 0.99% 23
2021
Q1
$253M Sell
3,445,230
-392,412
-10% -$28.9M 1.19% 11
2020
Q4
$300M Sell
3,837,642
-1,321,504
-26% -$101M 1.38% 8
2020
Q3
$408M Sell
5,159,146
-241,753
-4% -$18.9M 2.03% 4
2020
Q2
$399M Buy
5,400,899
+1,457,116
+37% +$110M 2.06% 2
2020
Q1
$290M Sell
3,943,783
-457,839
-10% -$36M 1.76% 6
2019
Q4
$382M Sell
4,401,622
-165,068
-4% -$13.6M 1.65% 6
2019
Q3
$367M Buy
4,566,690
+601,609
+15% +$48.2M 1.67% 5
2019
Q2
$317M Buy
3,965,081
+150,652
+4% +$11.5M 1.43% 12
2019
Q1
$303M Sell
3,814,429
-906,870
-19% -$67.8M 1.32% 12
2018
Q4
$344M Sell
4,721,299
-268,217
-5% -$18.9M 1.6% 7
2018
Q3
$338M Buy
4,989,516
+131,542
+3% +$8.38M 1.28% 15
2018
Q2
$281K Buy
4,857,974
+2,053,366
+73% +$116M 0.87% 24
2018
Q1
$146M Sell
2,804,608
-140,242
-5% -$7.57M 0.52% 74
2017
Q4
$158M Sell
2,944,850
-9,462
-0.3% -$525K 0.52% 72
2017
Q3
$181M Sell
2,954,312
-66,124
-2% -$4.01M 0.6% 58
2017
Q2
$185M Buy
3,020,436
+212,338
+8% +$12.9M 0.62% 60
2017
Q1
$170M Buy
2,808,098
+197,538
+8% +$12M 0.57% 67
2016
Q4
$147M Sell
2,610,560
-43,934
-2% -$2.57M 0.55% 74
2016
Q3
$158M Buy
2,654,494
+56,671
+2% +$3.31M 0.59% 63
2016
Q2
$143M Buy
2,597,823
+53,496
+2% +$2.85M 0.54% 70
2016
Q1
$128M Sell
2,544,327
-10,580
-0.4% -$518K 0.49% 77
2015
Q4
$129M Sell
2,554,907
-37,952
-1% -$1.91M 0.51% 69
2015
Q3
$122M Buy
2,592,859
+203,065
+8% +$10.8M 0.47% 77
2015
Q2
$130M Buy
2,389,794
+3,385
+0.1% +$190K 0.48% 71
2015
Q1
$131M Buy
2,386,409
+18,914
+0.8% +$1.07M 0.49% 71
2014
Q4
$128M Buy
2,367,495
+26,146
+1% +$1.46M 0.46% 69
2014
Q3
$132M Buy
2,341,349
+99,885
+4% +$5.61M 0.52% 64
2014
Q2
$124M Buy
2,241,464
+115,069
+5% +$6.28M 0.48% 70
2014
Q1
$115M Sell
2,126,395
-455,134
-18% -$23.6M 0.46% 75
2013
Q4
$123M Buy
2,581,529
+61,045
+2% +$2.79M 0.52% 70
2013
Q3
$115M Buy
2,520,484
+182,103
+8% +$8.31M 0.51% 74
2013
Q2
$104M Buy
+2,338,381
New +$104M 0.52% 72

Other funds holding MRK

Epoch Investment Partners's MRK Position: Q1 2026 in Review

Epoch Investment Partners reduced its Merck (MRK) stake by 1.3% in Q1 2026, selling an estimated $1.08M and leaving 701,092 shares worth $84.3M. The position accounts for 0.51% of the portfolio, ranked #79.

Epoch Investment Partners first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $408M in Q3 2020. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Epoch Investment Partners held 701,092 shares of Merck worth $84.3M as of Q1 2026.
  • Epoch Investment Partners sold 9,359 Merck shares in Q1 2026, an estimated $1.08M.
  • Merck made up 0.51% of Epoch Investment Partners's portfolio in Q1 2026, its #79 holding.
  • Epoch Investment Partners first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Epoch Investment Partners's Merck position peaked at $408M in Q3 2020.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Epoch Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.